BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) 

3210 Merryfield Row

San Diego  California  92121  U.S.A.
Phone: 858-450-2000 Fax: n/a


SEARCH JOBS




Industry
Biotechnology


Collaborations

Entelos, Inc. 





 Company News
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Scientists Uncover Previously Unknown Role for Class of Molecules 8/4/2011 2:52:19 PM
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA): In Study of Acutely Ill Patients Rivaroxaban Compares Favorably With Enoxaparin in Preventing Venous Thromboembolism but With an Increased Rate of Bleeding 4/5/2011 8:43:59 AM
Isogenica Limited Announces Collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) 3/22/2011 10:37:52 AM
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study 8/31/2010 10:07:02 AM
New Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Diabetes Drug, Canagliflozin Effective in Mid-Stage Study 6/28/2010 6:38:09 AM
WuXi PharmaTech Co., Ltd. Enters into Collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC (CA), a division of Janssen Pharmaceutica for Preclinical Services and Training 3/2/2010 8:43:07 AM
FDA Approves Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8/3/2009 7:45:20 AM
PPD, Inc. (PPDI) Confirms Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) Completion of Additional Phase III Studies Providing Expanded Safety and Efficacy Data for Priligy 6/10/2009 7:07:24 AM
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain 5/7/2009 12:10:39 PM
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 2/6/2009 8:31:36 AM
123456789